Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer

Summary

This randomized phase II trial studies how well ethyl icosapentate and physical activity work in treating fatigue in patients with cancer that has spread from where it started to other places in the body. Ethyl icosapentate and physical activity may provide more robust and clinically effective improvement of cancer related fatigue, which may facilitate patients continuing cancer therapy since it would be tolerated and effective in controlling disease.

Timeline

Start

2017-03-16

Primary completion

2020-11-24

Completion

2020-11-24

Drugs

Indications